Finance

Lists
NX1:ASX
Nexalis Therapeutics Ltd
A$0,0090
0,00%
(0,00) 1D
13 Okt., 14:25:51 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NX1...
Mkt. cap
2,28 m
Avg. vol.
37,25 k
Volume
0,00
52-wk high
A$0,03
52-wk low
A$0,01
EPS
-A$0,01
Shares outstanding
253,04 m
Mkt. cap
2,28 m
Avg. vol.
37,25 k
Volume
0,00
52-wk high
A$0,03
52-wk low
A$0,01
EPS
-A$0,01
Shares outstanding
253,04 m
News stories
From web sources and news partners
About Nexalis Therapeutics Ltd
CEO-
Employees-
Founded2016
Headquarters-
SectorPharmaceutical industry
Websiteinhalerx.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
217,49 k
217,49 k
315,05 k
315,05 k
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
376,83 k
376,83 k
637,88 k
637,88 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
182,51 k
182,51 k
235,88 k
235,88 k
Operating expense
559,06 k
559,06 k
903,79 k
903,79 k
Total operating expenses
559,06 k
559,06 k
903,79 k
903,79 k
Operating income
-341,56 k
-341,56 k
-588,73 k
-588,73 k
Other non operating income
-
-
-
-
EBT including unusual items
-382,22 k
-382,22 k
-648,97 k
-648,97 k
EBT excluding unusual items
-382,22 k
-382,22 k
-648,97 k
-648,97 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-13,90 k
-13,90 k
29,15 k
29,15 k
Net income
-382,22 k
-382,22 k
-648,97 k
-648,97 k
Net profit margin
-175,74%
-175,74%
-205,99%
-205,99%
Earnings per share
-
-
-
-
Interest and investment income
32,00
32,00
537,00
537,00
Interest expense
-40,69 k
-40,69 k
-60,77 k
-60,77 k
Net interest expenses
-40,66 k
-40,66 k
-60,24 k
-60,24 k
Depreciation and amortization charges
-
-
877,00
877,00
EBITDA
-
-
-587,86 k
-587,86 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme